We examined the status of GNAS mutation at codon 201 and KRAS mutation at codon 12&13, degree of mucin production and immunohistochemical expressions of MUC mucin core proteins in 29 individuals (M/F=15/14) with IPNB in intrahepatic and perihilar bile ducts (perihilar IPNB) and 6 individuals (M/F=5/1) with IPNB in distal bile ducts (distal IPNB). 15/14) with IPNB in intrahepatic and perihilar bile ducts (perihilar IPNB) and 6 individuals (M/F = 5/1) with IPNB in distal bile ducts (distal IPNB). GNAS mutations and KRAS mutations Benzethonium Chloride were recognized in 50% and 46.2% of IPNBs, respectively. There was no significant correlation between the status of GNAS mutation and clinicopathological factors in IPNBs, whereas, the status of KRAS mutation was significantly inversely correlated with the degree of MUC2 manifestation in IPNBs (p<0.05). All IPNBs with GNAS mutation only showed high-mucin production. Degree of mucin production was significantly higher in perihilar IPNBs than distal IPNBs (p<0.05). MUC2 and MUC5AC manifestation was significantly higher in IPNBs with high-mucin production than those with low-mucin production (p<0.01 and p<0.05, respectively). In conclusions, this study firstly disclosed frequent GNAS mutations in IPNBs, similarly to IPMNs. This may suggest a common histopathogenesis of IPNBs and IPMNs. The status of KRAS mutations was inversely correlated to MUC2 manifestation and this may suggest heterogeneous properties of IPNBs. IPNBs with high-mucin production are characterized by perihilar location and high manifestation of MUC2 and MUC5AC, irrespective of the status of GNAS and KRAS mutations. == Intro == Intraductal FLJ39827 papillary neoplasm of the bile duct (IPNB) is definitely characterized by dilated intrahepatic bile ducts Benzethonium Chloride filled with noninvasive papillary or villous biliary neoplasm covering delicate fibrovascular stalks[1]. IPNB includes the previous categories of biliary papilloma and papillomatosis, and the term IPNB has been used in WHO classification 2010[1]. IPNB is regarded as a biliary counterpart of intraductal papillary mucinous neoplasm of the pancreas (IPMN) and shows favorable prognosis[1][3]. In addition, IPNBs are not infrequently associated with invasive carcinoma (IPNB with an associated with invasive carcinoma)[1]. Some IPNBs display excessive mucin secretion and are explained using the terms mucin-producing bile duct tumor, mucin-hypersecreting bile duct tumor, or IPNB with macroscopically mucin-producing biliary tumor[4][6]. This subset of IPNB is definitely associated with hepatolithiasis[7]and has a tendency to display intestinal differentiation[4],[7],[8]. Guanine nucleotide-binding protein, -stimulating activity polypeptide (GNAS) encodes the -subunit of the stimulatory G-protein (Gs), which mediates the rules of adenylate cyclase activity through G-protein-coupled receptors. Activating mutations of GNAS at codon 201 have been detected in approximately two thirds of IPMNs of the pancreas[9],[10]. In addition, frequent GNAS mutations were reported in pituitary adenomas, colorectal villous adenomas and pyloric gland adenomas[11],[12]. In contrast to frequent mutation of GNAS in IPMNs, there have been few GNAS mutations in typical invasive ductal carcinoma of the pancreas (PDAC)[9],[10]. There have been only a few studies on GNAS mutation in cholangiocarcinomas and IPNBs, to our knowledge[13][15]. GNAS mutations were reportedly uncommon in IPNBs inside a earlier study[15]. GNAS mutation was not recognized in cholangiocarcinomas and biliary intraepithelial neoplasia (BilIN) in our earlier study[14]. v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation is an early event within PanINs and happens in up to Benzethonium Chloride 90% of early PanINs and in 95% pancreatic adenocarcinomas (PDACs)[16],[17]. KRAS mutation was recognized in about a third of cholangiocarcinomas and BilINs[14]. Given frequent GNAS mutations in IPMNs, which are similar to IPNBs, we examined the status of GNAS and KRAS mutations. Furthermore, we analyzed their association with clinicopathological factors including the degree of mucin production and the manifestation of MUC mucin core proteins (MUC1, MUC2, MUC5AC, MUC5B and MUC6). == Materials and Methods == == Classification of the biliary tree and IPNBs == The biliary tree is definitely divided into intrahepatic, perihilar (the right, remaining and common hepatic ducts) and distal bile duct (extrahepatic bile ducts distal to the insertion of the cystic duct)[18]. The intrahepatic bile duct is definitely classified as explained previously[18]. IPNB were classified into perihilar and distal IPNB based on the location of tumor according to the TNM Benzethonium Chloride classification of malignant tumors[19]. == Preparation of human being IPNB cells specimens == We examined 29 individuals with perihilar IPNB (12 non-invasive, 3 microinvasive and 14 invasive, M/F Benzethonium Chloride = 15/14) and 6 distal IPNB (all invasive M/F = 5/1). We defined the IPNB with microinvasion as IPNB with small foci of invasion in which the deepest invasion is limited to the mucosa with this study. The medical and pathological features were summarized in Table. 1. Mucinous cystic neoplasms with ovarian-like stroma were excluded. Participants offered their written educated consent to participate in this study. The Ethics Committee of Kanazawa University or college authorized this study and consent process. When the written consent was not obtained because of old samples, such samples were.